- Country: Azerbaijan
- Summary: Purchase of "Medicines Within the Framework of Measures to Combat the Genetic Disease Cystic Fibrosis in Children" (For 2025)
- AZT Ref No: 112494156
- Deadline: 28 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: AZN 601008.22
- Notice Type: Tender
- Document Ref. No.: 103457
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Dornaza, Dornaza alfa 2500BV/2.5ml #30, Qty- 350, Measurement unit - box
Budesonide, Budesonide Micronized 0.25mg/ml 2ml #20, Qty- 100, Measurement unit - box
Budesonide, Budesonide Micronized 0.5mg/ml 2ml #20, Qty- 200, Unit of measure -box
Pancreatin,Pancreatin 10000 BV N20, Qty- 4.000, Unit of measure -box
Pancreatin,Pancreatin - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPurchase of "Medicines Within the Framework of Measures to Combat the Genetic Disease Cystic Fibrosis in Children" (For 2025) - Azerbaijan Tender
The INNOVATION AND SUPPLY CENTER PUBLIC LEGAL ENTITY, a Government sector organization in Azerbaijan, has announced a new tender for Purchase of "Medicines Within the Framework of Measures to Combat the Genetic Disease Cystic Fibrosis in Children" (For 2025). This tender is published on AzerbaijanTenders under AZT Ref No: 112494156 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-28.
The estimated tender value is AZN 601008.22, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
